KH Medical

What KH Medical does

KH Medical Co., Ltd. (케이에이치메디칼) is a privately held South Korean in vitro diagnostics manufacturer founded in 2018 by CEO Hong Man-hyeong, headquartered in Pyeongtaek-si, Gyeonggi-do with a 10x-expanded manufacturing and research institute footprint. The company operates as a Total Solution Provider across three diagnostic verticals: molecular diagnostics (the RADI series of RT-PCR kits and the RADIONE POCT-PCR system for pathogens including Mpox, Ebola, COVID-19, Malaria, Dengue, Hantavirus, HPV, MTB/NTM, and STI panels), immunodiagnostics (UniCare immunoassay reagents for Malaria and SARS-CoV-2/Flu), and veterinary diagnostics (TTAni series including the TTAniKoReader immunofluorescence analyzer, ELISA kits, and rapid tests for canine and feline pathogens). Core technology platforms include RT-PCR and RT-LAMP amplification chemistry, magnetic bead-based automated nucleic acid extraction (RADI MX-16 with orbital shaking up to 2,000 rpm, and RADI Extractor 192 with up to 7,000 samples/day throughput), and a proprietary high-sensitivity color sensor for immunofluorescence quantification. The company holds ISO 13485, ISO 9001, GMP, CE-IVD, and KFDA Export Only certifications, plus an Africa CDC recommendation for its Mpox kit, and has registered patents on nucleic acid extraction/amplification apparatus and sample container designs.

The revenue model combines one-time sales of diagnostic reagent kits (PCR, ELISA, rapid tests, immunoassay reagents) with hardware sales of automated extractors, POCT-PCR systems, and immunofluorescence analyzers. KH Medical distributes through direct export to approximately 40 countries, partnerships with international organizations (KOICA, Africa CDC, US CDC, UNICEF, A Menarini Diagnostics, Bangui Pasteur Institute), channel/reseller relationships built at international trade shows (MEDICA, Medipharm Vietnam, Singapore Vet Show), and one jointly-controlled diagnostic center — KOICA-KH Lab in Accra, Ghana, opened December 2023 under KOICA's Inclusive Business Solution program. End customers are predominantly government health ministries, national public health agencies, and donor-funded outbreak response programs in developing countries, with Europe, Southeast Asia, and the veterinary channel representing growth diversification efforts.

KH Medical's stated value proposition is a low-cost, fast-turnaround alternative to conventional RT-PCR — equipment priced at roughly one-tenth of competing systems, PCR results in 40 minutes versus 2–6 hours, and 100% sensitivity/specificity as validated by FIND clinical trials. The company is founder-owned and reportedly bootstrapped (no disclosed external venture capital), growing from approximately $300,000 in 2019 exports to earning the Korean government's $5 million Export Tower Award within roughly two years of establishment. Revenue figures should be interpreted with caution: one 2021 article references 200 billion KRW (~$150M USD) achieved by August 2021 with a 400–500 billion KRW full-year projection, which is internally inconsistent with the $5M Export Tower benchmark and likely reflects total or contracted revenue rather than pure export; current revenue cannot be reliably triangulated from the available data.

Name

KH Medical

Legal name

(주)케이에이치메디칼

Website

https://khmedical.co.kr

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

KH Medical Co., Ltd. is a South Korean in vitro diagnostics manufacturer founded in 2018 that develops molecular, immunoassay, and veterinary diagnostic kits and instruments (RADI, RADIONE, TTAni, UniCare brands), exporting to approximately 40 countries with a focus on government and donor-funded outbreak response programs in developing markets, particularly Africa.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841), Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industries

Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Veterinary POCT & Rapid Diagnostics (Animal health rapid tests) (HLAHAOAL), Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI), Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy) (HLAMAFAI), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Molecular diagnostics
• Immunoassay reagents
• Veterinary diagnostics
• Nucleic acid extraction
• Point-of-care PCR

Headquarters

HQ city

Gyeongju

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Reagent Sales: Sale of molecular diagnostic kits, rapid test kits, ELISA kits, and immunofluorescence test kits for human and veterinary diagnostics. Products include RADI FAST series, TTAni series, and UniCare series.
2. Diagnostic Equipment Sales: Sale of automated nucleic acid extraction equipment (RADI MX-16, RADI Extractor 192, RADI CONCENT+), immunofluorescence analyzers (TTAniKoReader, UniKoReader), and POCT-PCR systems (RADIONE, RADIONE 4ch).
3. Extraction Kit Sales: Sale of specialized extraction kits including RADI Viral DNA/RNA Extraction Kit, Blood DNA Extraction Kit, Cell-free DNA Extraction Kit, Universal DNA/RNA Extraction Kit for various sample types.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

KH Medical manufactures and supplies in vitro diagnostic products and instruments, including automated nucleic acid extraction systems (RADI MX-16, RADI Extractor 192), an integrated POCT-PCR platform (RADIONE), an immunofluorescence analyzer (TTÅniKoReader), and a broad portfolio of PCR detection kits, rapid antigen tests, ELISA kits, and immunoassay reagents for human infectious disease and veterinary diagnostics.

Product overview

KH Medical is a Total Solution Provider for Molecular Diagnostics, Immunoassay Diagnostics, and Veterinary Diagnostics. The company offers integrated diagnostic systems comprising instruments (automated extractors, POCT-PCR systems, immunofluorescence analyzers, ELISA processors) and配套 reagents (extraction kits, detection kits, rapid tests, immunoassay reagents, ELISA kits). Key product lines include the RADI series for human diagnostics (including RADI MX-16, RADI Extractor 192 automated extractors, RADIONE POCT-PCR systems, RADI MPOX Detection Kit, and various molecular and rapid diagnostic tests) and the TTÅni series for veterinary diagnostics (including TTÅniKoReader immunofluorescence analyzer and comprehensive ELISA and rapid test panels for canine, feline, and other animal diseases). The company maintains ISO 13485, ISO 9001, and GMP certifications, with products carrying CE-IVD marking and various regulatory approvals for global markets.

Differentiator

Problem solved

Functional benefit

Brands

• RADI: Molecular diagnostics and extraction equipment brand including RADI COVID-19, RADI FAST Mpox, RADI Ebola, RADI Malaria detection kits and RADI MX-16, RADI Extractor automated nucleic acid extraction equipment
• RADIONE
• TTÅniKoReader
• TTÅni
• UniCare
• KOICA-KH Lab

Products and services

• RADI MX-16

Quantifiable outcome

• 100% sensitivity and specificity achieved in FIND clinical trials
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• KOICA (Korea International Cooperation Agency)coreStrategic or Co-development PartnerPartnership through KOICA's Inclusive Business Solution (IBS) program to establish KOICA-KH Lab diagnostic centers in Africa, starting with Accra, Ghana. KOICA Ghana office and Ghana Ministry of Health participated in the opening ceremony on December 6. Collaboration for public health environment improvement and Mpox response planning.
• Africa CDCcoreStrategic or Co-development PartnerRADI Fast Mpox detection kit listed on Africa CDC's List of Recommended Real-Time (RT) PCR Tests for Mpox. Collaboration to address Mpox outbreak in Africa through recommended diagnostic products.
• Bangui Pasteur InstitutecoreStrategic or Co-development PartnerCollaborative partnership for Mpox outbreak response in Africa, working together to address public health challenges.
• US CDC (Centers for Disease Control and Prevention)coreStrategic or Co-development PartnerInternational research cooperation with US CDC located in Atlanta from company establishment. Collaboration on diagnostic reagent and system development with leading international research institutions.
• Green Cross Holdings (녹십자홀딩스)minorOthersListed as cooperative partner on company website.
• Chonnam National University Hospital (전남대학교병원)minorStrategic or Co-development PartnerListed as cooperative partner on company website for research and development collaboration.
• UNICEFminorChannel Partner/ Reseller/ DistributorListed as cooperative partner on company website.
• A Menarini DiagnosticsminorChannel Partner/ Reseller/ DistributorListed as cooperative partner on company website.
• KOICA-KH Lab GhanacoreChannel Partner/ Reseller/ DistributorDiagnostic center operated in Accra, Ghana in partnership with KOICA. Established as part of IBS program to improve public health environment and respond to disease outbreaks including Mpox.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Cepheid (Danaher): US-based molecular diagnostics leader behind the GeneXpert platform, widely deployed in global health tenders (TB, HIV, Ebola, SARS-CoV-2) including across Africa. Comparable as a broad incumbent defining reference pricing and procurement standards that KH Medical must compete against in the same low-resource settings.
• bioMérieux: French in-vitro diagnostics company with the BioFire FilmArray syndromic panels and a strong global health footprint. Comparable as a broad incumbent offering automated molecular diagnostics and a large outbreak pathogen menu that overlaps with KH Medical's portfolio.
• Abbott Diagnostics: Global IVD leader with the Alinity m and m2000 molecular diagnostics systems plus rapid antigen tests (Binax, Panbio) widely used in Africa. Comparable as a broad incumbent in molecular and rapid diagnostics whose pricing and supply continuity decisions directly affect KH Medical's market access.

Regional players

• DAAN Gene: Chinese molecular diagnostics company with a broad real-time PCR and NGS-based infectious disease test menu and large emerging-market distribution. Comparable as a regional (non-Korean) IVD competitor that often bids into the same African and Southeast Asian tenders as KH Medical.

Direct peers

• GenBody: Korean in-vitro diagnostics company producing rapid antigen and molecular diagnostic test kits for infectious diseases, with established distribution in Asia, Latin America, and Africa. Similar product portfolio (COVID, tropical disease rapid/molecular tests) and emerging-market go-to-market focus.
• SD Biosensor: South Korean IVD manufacturer of rapid diagnostic tests and molecular diagnostics, including COVID-19 antigen and PCR kits with a strong global presence in emerging markets. Directly comparable as a Korean IVD peer that scaled rapidly on COVID-19 demand and focuses on developing-country distribution.
• Seegene: South Korea-based molecular diagnostics company specializing in multiplex PCR technologies for infectious disease detection. Closely comparable to KH Medical as a Korean-headquartered IVD company with a similar focus on real-time PCR reagents for pathogens and a strong international export footprint.
• SolGent: Korean molecular diagnostics company focused on real-time PCR diagnostic kits for infectious diseases including COVID-19, Mpox, dengue, and respiratory pathogens. Comparable as a Korea-based molecular IVD peer with similar pathogen menu and export orientation.

Emerging players

• Credo Diagnostics Biomedical: Emerging player in point-of-care molecular diagnostics ( VitaPCR platform) targeting near-patient infectious disease testing in clinics and field settings. Comparable to KH Medical's RADIONE POCT-PCR product line as a focused emerging POC-molecular competitor.
• Mesa Labs: US-based diagnostics and life sciences tools company with rapid molecular and lateral flow test products including the Accula point-of-care PCR system for infectious diseases. Comparable as a focused emerging player in decentralized molecular diagnostics overlapping with KH Medical's POCT-PCR strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/khmedical

Compliance26 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KH Medical